Spinal Cord Stimulation for Functional Recovery in Tetraplegia
This study is investigating if a non-invasive treatment called transcutaneous electrical spinal stimulation (TESS) can help improve arm and hand movement in people with spinal cord injuries (SCI). TESS delivers small electrical pulses to your spine at C5-6. Researchers will compare TESS with a sham-TESS (inactive stimulation) and combine it with motor training, where you'll practice repetitive arm and hand movements. The study aims to see how TESS affects your upper-limb muscles and if it can improve your ability to reach and grasp. Success will be measured by changes in muscle responses and improvements in your GRASSP Test scores, which assess hand function. The study is currently recruiting 86 Veterans, aged 18-70, with chronic cervical SCI (at least one year after injury, at C8 or above).
- Study design
- This interventional study plans to enroll 86 participants and involves different groups receiving either TESS or sham-TESS, combined with motor training.
- What's involved
- You would participate in two randomized sessions initially, then potentially 20 sessions (3-5 per week) involving TESS or sham-TESS and motor tasks over an average of 5 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your progress will be followed through study completion (average of 5 weeks) and during a 6-month follow-up period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Spinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Monica A Perez, PhD · PRINCIPAL_INVESTIGATOR · Edward Hines Jr. VA Hospital, Hines, IL
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Changes in amplitude of Motor evoked potential sizeChange from baseline at study completion, average of 5 weeks
Ten stimuli (0.2 Hz) will be delivered at each intensity to plot the mean peak-to-peak amplitude of the MEP from the non-rectified response against the TMS intensity in each subject (MEP recruitment curve).
- Change in GRASSP TestThrough study completion(average of 5 weeks) and during 6-month follow-up
The GRASSP will be used to asses several domains of arm/hand function in humans with cervical SCI, specifically assessing three domains of hand function: 1) strength, 2) sensibility, and 3) prehension. The time to administer the test is \~45 min. The GRASSP has 5 subsets: * Dorsal sensation: (3 locations, each scored 0-4, sum=0-12) * Palmar sensation: (3 locations, each scored 0-4, sum=0-12) * Strength: (10 muscles of arm and hand, motor score 0-5, sum=0-50) * Prehension ability: (3 grasps (cylindrical, lateral key, tip to tip), each scored 0-4, sum=0-12) * Prehension performance: There are 6 prehension tasks. Pouring water from a bottle, opening jars, picking up and turning a key, transferring 9 pegs from board to board, picking up four coins and place in slots, screwing four nuts onto bolts. Each task is scored 0-5, sum=0-30.
- Changes in amplitude of cervicomedullary motor evoked potential sizeChange from baseline at study completion, average of 5 weeks
Ten Transcranial magnetic stimuli (TMS) will be delivered to plot the mean peak-to-peak amplitude of the motor and cervicomedullary evoked potentials (MEPs and CMEPs, respectively) from the non-rectified response against the TMS intensity in each subject (MEP/CMEP recruitment curves).